Cleo vs AI21 Jamba
Detailed side-by-side comparison to help you choose the right tool
Cleo
Automation & Workflows
AI-powered clinical decision support platform for acute care hospitals, providing real-time patient deterioration detection, sepsis prediction, and workflow optimization to improve outcomes and reduce clinician burnout.
Was this helpful?
Starting Price
CustomAI21 Jamba
🔴DeveloperAutomation & Workflows
AI21's hybrid Mamba-Transformer foundation model with a 256K token context window, built for fast, cost-effective long-document processing in enterprise pipelines. Trades reasoning depth for throughput and price.
Was this helpful?
Starting Price
$2.00/M tokens (Jamba Large)Feature Comparison
Scroll horizontally to compare details.
Cleo - Pros & Cons
Pros
- ✓Aims to consolidate deterioration detection, sepsis prediction, and capacity management into a single acute-care-focused platform, potentially reducing the need to procure and integrate multiple point solutions
- ✓Claims direct integration into existing EHR workflows (Epic, Cerner) so clinicians don't need to learn a separate application
- ✓Configurable alert sensitivity reportedly allows clinical informatics teams to tune the system to their facility's tolerance for alert fatigue
- ✓Describes explainable risk scores showing contributing factors, which if validated would enable clinicians to make informed decisions rather than relying on black-box outputs
- ✓Covers multiple acute care use cases within a single platform, unlike competitors that typically specialize in one domain (imaging, operations, or sepsis scoring alone)
Cons
- ✗Independent verification of the product, its customer base, and clinical outcomes is extremely limited — no peer-reviewed studies, named references, or specific outcome data are publicly available
- ✗Enterprise-only pricing (estimated at $50,000+/year based on comparable platforms) makes it inaccessible for small or rural hospitals without dedicated AI budgets
- ✗As a newer entrant, Cleo lacks the established install base and track record of competitors like Qventus, Viz.ai, or Epic's native tools, increasing procurement risk
- ✗Implementation requires a multi-week integration and calibration period, which may delay time-to-value by 2–3 months
- ✗Limited to acute care settings — organizations looking for outpatient, primary care, or population health AI will need a separate solution
- ✗FDA clearance status is not publicly documented, and no clinical validation studies are available in public databases such as PubMed
AI21 Jamba - Pros & Cons
Pros
- ✓256K token context window that actually sustains throughput on long inputs, enabled by the hybrid Mamba-Transformer architecture rather than retrofitted attention tricks
- ✓Significantly faster and cheaper per token on long-document workloads than comparably-sized pure-Transformer models, due to linear-scaling SSM layers
- ✓Open weights available for Jamba Mini and Jamba Large on Hugging Face, making on-prem, VPC, and air-gapped deployment genuinely possible for regulated customers
- ✓Available across all major enterprise channels (AWS Bedrock, Azure, Vertex, Snowflake Cortex, Databricks), so procurement and data-residency requirements are easier to satisfy
- ✓Strong grounding behavior on retrieval-augmented workloads, with AI21 tuning the model specifically for RAG and document QA rather than open-ended chat
- ✓Pairs cleanly with AI21's Maestro orchestration layer for building multi-step agents that need large working context
Cons
- ✗Reasoning, math, and coding performance trail frontier models like GPT-4-class, Claude Opus/Sonnet, and Gemini 2.x — Jamba is a throughput model, not a reasoning champion
- ✗Smaller developer ecosystem and fewer community tutorials, wrappers, and evals compared to OpenAI, Anthropic, or Meta Llama families
- ✗Self-hosting the open weights still requires substantial GPU infrastructure, especially for Jamba Large, so 'open' does not mean 'cheap to run' for most teams
- ✗Quality on short-prompt, conversational tasks is less differentiated — the architectural advantage only really shows up on long contexts
- ✗Public benchmark coverage is thinner than for the major frontier labs, making apples-to-apples evaluation harder before committing to a deployment
Not sure which to pick?
🎯 Take our quiz →🦞
🔔
Price Drop Alerts
Get notified when AI tools lower their prices
Get weekly AI agent tool insights
Comparisons, new tool launches, and expert recommendations delivered to your inbox.